Isosceles Pharmaceuticals, Inc. https://validator.w3.org/feed/docs/rss2.html Dr. Mike Caliguiri, MD Dr. Herbert Neuman MD, MBA Nathaniel Hernandez, PhD Mark A. Mannebach, PhD, RPh Home ESG Impact Investing Rebecca Johnson William Humphries, MBA Team Brett J. Lanier Deborah Mosca, PhD Dr. Mike A. Royal, MD, JD, MBA Hunter Land, MS News Kevin Fickle Devin Bosch Dr. Robert B. Stein, MD, PhD Contact Us Pipeline Winners Of Inaugural NC BIONEER Venture Challenge Announced Isosceles Pharmaceuticals Wins Coastal Entrepreneur Award Tapping Synthetic CBD For Pain Relief Isosceles Pharmaceuticals appoints Herbert Neuman, MD, MBA Chief Medical Officer and adds Thomas Harrison, LH.D as a strategic advisor Isosceles Pharmaceuticals Signs Non-Binding Letter of Intent With a Strategic Partner for Phase 1 Development of Its Proprietary Synthetic Cannabidiol Intravenous Product Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as its Chief Executive Officer Tim Wright Thomas L. Harrison, LH.D. About Us Dr. Michael Giuliani, MD